Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 391 AL 405

The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease

Mesiti F, Chavarria D, Gaspar A, Alcaro S, Borges F.

Eur J Med Chem. 2019 Nov 1;181:111572. doi: 10.1016/j.ejmech.2019.111572. Epub 2019 Aug 1.

Ketogenic Diet in Alzheimer's Disease

Rusek M, Pluta R, Ułamek-Kozioł M, Czuczwar SJ.

Int J Mol Sci. 2019 Aug 9;20(16):3892. doi: 10.3390/ijms20163892.

Comparison of Retinal Microvasculature in Patients With Alzheimer's Disease and Primary Open-Angle Glaucoma by Optical Coherence Tomography Angiography

Zabel P, Kaluzny JJ, Wilkosc-Debczynska M, Gebska-Toloczko M, Suwala K, Zabel K, Zaron A, Kucharski R, Araszkiewicz A.

Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3447-3455. doi: 10.1167/iovs.19-27028.

Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives

Lanzillotta C, Di Domenico F, Perluigi M, Butterfield DA.

CNS Drugs. 2019 Oct;33(10):957-969. doi: 10.1007/s40263-019-00658-8.

Herpes simplex virus type 1 and Alzheimer's disease: link and potential impact on treatment

Mancuso R, Sicurella M, Agostini S, Marconi P, Clerici M.

Expert Rev Anti Infect Ther. 2019 Sep;17(9):715-731. doi: 10.1080/14787210.2019.1656064. Epub 2019 Aug 23.

The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer's disease

Giorgi FS, Saccaro LF, Galgani A, Busceti CL, Biagioni F, Frati A, Fornai F.

Brain Res Bull. 2019 Nov;153:47-58. doi: 10.1016/j.brainresbull.2019.08.007. Epub 2019 Aug 13.

Are TallyHo Mice A True Mouse Model for Type 2 Diabetes and Alzheimer's Disease?

Ramasubramanian B, Reddy PH.

J Alzheimers Dis. 2019;72(s1):S81-S93. doi: 10.3233/JAD-190613.

Involvement of organelles and inter-organellar signaling in the pathogenesis of HIV-1 associated neurocognitive disorder and Alzheimer's disease

Khan N, Haughey NJ, Nath A, Geiger JD.

Brain Res. 2019 Nov 1;1722:146389. doi: 10.1016/j.brainres.2019.146389. Epub 2019 Aug 16.

[Neuroinflammation as motor of Alzheimer's disease]

Castro-Gomez S, Binder J, Heneka MT.

Nervenarzt. 2019 Sep;90(9):898-906. doi: 10.1007/s00115-019-0778-3.

Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease

Singh AK, Singh SK, Nandi MK, Mishra G, Maurya A, Rai A, Rai GK, Awasthi R, Sharma B, Kulkarni GT.

Cent Nerv Syst Agents Med Chem. 2019;19(3):154-170. doi: 10.2174/1871524919666190820160053.

Development of new treatments for Alzheimer's disease based on the modulation of translocator protein (TSPO)

Arbo BD, Ribeiro MF, Garcia-Segura LM.

Ageing Res Rev. 2019 Sep;54:100943. doi: 10.1016/j.arr.2019.100943. Epub 2019 Aug 17.

Ghrelin in Alzheimer's disease: Pathologic roles and therapeutic implications

Jeon SG, Hong SB, Nam Y, Tae J, Yoo A, Song EJ, Kim KI, Lee D, Park J, Lee SM, Kim JI, Moon M.

Ageing Res Rev. 2019 Nov;55:100945. doi: 10.1016/j.arr.2019.100945. Epub 2019 Aug 18.

Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer's disease: a cumulative meta-analysis and trial sequential analysis

Blanco-Silvente L, Castells X, Garre-Olmo J, Vilalta-Franch J, Saez M, Barceló MA, Capellà D.

Eur J Clin Pharmacol. 2019 Dec;75(12):1659-1667. doi: 10.1007/s00228-019-02742-w. Epub 2019 Aug 21.

Management of oxidative stress and other pathologies in Alzheimer's disease

Simunkova M, Alwasel SH, Alhazza IM, Jomova K, Kollar V, Rusko M, Valko M.

Arch Toxicol. 2019 Sep;93(9):2491-2513. doi: 10.1007/s00204-019-02538-y. Epub 2019 Aug 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias